Pre-earnings options volume in Iovance Biotherapeutics (IOVA) is 2.2x normal with calls leading puts 8:7. Implied volatility suggests the market is anticipating a move near 12.4%, or 67c, after results are released. Median move over the past eight quarters is 7.6%.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA:
- Iovance Biotherapeutics (IOVA) Q4 Earnings Cheat Sheet
- Iovance Biotherapeutics call volume above normal and directionally bullish
- Iovance Biotherapeutics appoints Kirby as Chief Commercial Officer
- Iovance Biotherapeutics price target lowered to $7.50 from $10 at Piper Sandler
- Iovance Biotherapeutics (IOVA) Forecasts Strong Growth Due to Flagship Treatment